Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight

Autor: Susan J. Allison, Ernie Yulyaningsih, Bernhard Stehrer, Amanda Sainsbury, Yan C. Shi, En-Ju D. Lin, Aygul Aljanova, John A. Eisman, Shu Lin, Iris P. L. Wong, Lei Zhang, Paul A. Baldock, Matthew J. During, Frank Driessler, Herbert Herzog, Katy Slack, Michelle M. McDonald, Ronald F. Enriquez, David G. Little, Dominique D. Pierroz, Serge Ferrari, Nicola J. Lee
Rok vydání: 2009
Předmět:
Male
lcsh:Medicine
Diabetes and Endocrinology/Bone and Mineral Metabolism
Mice
0302 clinical medicine
Osteogenesis
Neuropeptide Y
lcsh:Science
Adiposity
2. Zero hunger
Mice
Knockout

0303 health sciences
Multidisciplinary
Osteoblast
Organ Size
Neuropeptide Y receptor
humanities
RUNX2
medicine.anatomical_structure
Phenotype
Hypothalamus
Knockout mouse
Female
medicine.drug
Signal Transduction
Research Article
medicine.medical_specialty
Neuropeptide
030209 endocrinology & metabolism
Biology
Models
Biological

Bone and Bones
03 medical and health sciences
Internal medicine
Orexigenic
Neuropeptide Y/*deficiency/metabolism
mental disorders
medicine
Animals
Molecular Biology
Body Weight/*physiology
030304 developmental biology
Physiology/Endocrinology
lcsh:R
Body Weight
Hypothalamus/cytology/metabolism
Endocrinology
Bone and Bones/*anatomy & histology/cytology/metabolism
ddc:618.97
lcsh:Q
Homeostasis
Neuroscience
Zdroj: PLoS ONE
PLoS ONE, Vol 4, Iss 12, p e8415 (2009)
PLOS ONE, Vol. 4, No 12 (2009) P. e8415
ISSN: 1932-6203
Popis: Changes in whole body energy levels are closely linked to alterations in body weight and bone mass. Here, we show that hypothalamic signals contribute to the regulation of bone mass in a manner consistent with the central perception of energy status. Mice lacking neuropeptide Y (NPY), a well-known orexigenic factor whose hypothalamic expression is increased in fasting, have significantly increased bone mass in association with enhanced osteoblast activity and elevated expression of bone osteogenic transcription factors, Runx2 and Osterix. In contrast, wild type and NPY knockout (NPY (-/-)) mice in which NPY is specifically over expressed in the hypothalamus (AAV-NPY+) show a significant reduction in bone mass despite developing an obese phenotype. The AAV-NPY+ induced loss of bone mass is consistent with models known to mimic the central effects of fasting, which also show increased hypothalamic NPY levels. Thus these data indicate that, in addition to well characterized responses to body mass, skeletal tissue also responds to the perception of nutritional status by the hypothalamus independently of body weight. In addition, the reduction in bone mass by AAV NPY+ administration does not completely correct the high bone mass phenotype of NPY (-/-) mice, indicating the possibility that peripheral NPY may also be an important regulator of bone mass. Indeed, we demonstrate the expression of NPY specifically in osteoblasts. In conclusion, these data identifies NPY as a critical integrator of bone homeostatic signals; increasing bone mass during times of obesity when hypothalamic NPY expression levels are low and reducing bone formation to conserve energy under 'starving' conditions, when hypothalamic NPY expression levels are high.
Databáze: OpenAIRE